Welcome to Biotalk presented by Locust Walk. Biotalk is a podcast for biotech leaders. Join us as we share insights into trends and opportunities, and make predictions on where the industry is headed based on key statistics.
Biotalk Episode 12: A Conversation with Soufiane Aboulhouda of Nucleate
On this episode of Biotalk, Locust Walk‘s Geoff Meyerson welcomes Soufiane Aboulhouda, Co-Founder and Chairman of the Board of Nucleate, a global non-profit dedicated to empowering future biotech leaders through education and fostering innovation in life sciences companies. The discussion explores Soufiane’s journey into early-stage biotech and delves into the founding story of Nucleate, highlighting the […]
Biotalk Episode 11: A Conversation with Shehnaaz Suliman of ReCode Therapeutics
On this episode of Biotalk, Locust Walk‘s Daniel Brog welcomes with Shehnaaz Suliman, M.D., CEO of ReCode Therapeutics, a clinical-stage genetic medicines company using its selective organ targeting lipid nanoparticle platform to power the next wave of mRNA and gene correction therapeutics. With over 25 years of experience, Shehnaaz brings a multifaceted perspective to the discussion. She […]
Biotalk Episode 10: A Conversation with Errik Anderson of Alloy Therapeutics
On this episode of Biotalk, Locust Walk‘s Geoff Meyerson welcomes Errik Anderson, CEO and Founder of Alloy Therapeutics, to the podcast. Alloy is a trailblazing drug-discovery company, bringing collaborative platforms and services to the biotech world, making cutting-edge biologics accessible to everyone, from academia and small biotechs to major pharmaceutical companies. Errik, with a unique blend of entrepreneurship, […]
Biotalk Episode 9 2023 Q3 Report: Global Trends in Biopharma Transactions
During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, delves into our 2023 Q3 Report: Global Trends in Biopharma Transactions Report. Each quarter, Locust Walk’s deal team compiles key statistics and trends showcasing the current state of global private and public capital markets, strategic partnerships, and M&A in the biopharma sector. In this […]
Biotalk Episode 8: A Conversation with Helen Ho of Blueprint Medicines
Biotalk Episode 7: A Conversation with Howard Federoff of Ryne Biotechnology
Loved your 1st podcast. Looking forward to learning more.